Self‐assembly preparation of Zn2+‐immobilized silica hybrid monolith and application in solid‐phase micro‐extraction of β‐agonists.

Exploiting adsorbents with highly efficient extraction performance is of great promise for extracting small organic molecules from biological samples. In this work, a novel Zn2+‐immobilized chitosan@silica hybrid monolith was prepared through a simple self‐assembly Zn2+‐immobilization process. Exploited as an adsorbent in solid‐phase micro‐extraction for extracting trace β‐agonists, the monolith exhibited high extraction efficiencies for salbutamol, clenbuterol, and ractopamine with the enrichment factors approaching 120, 85, and 52, respectively. These could be attributed to the effective interaction between Zn2+ ions and the target molecule via coordination or other intermolecular interactions. Under optimized extraction operations, a sensitive determination was successfully developed coupling with high‐performance liquid chromatography‐ultraviolet detection. The linear range was 0.17–58.8, 0.12–68.5, and 0.18–65.5 ng/ml for salbutamol, clenbuterol, and ractopamine. The limits of detection of the β‐agonists were from 0.04 to 0.07 ng/ml, and the limits of quantification were from 0.12 to 0.18 ng/ml. The recoveries of spiking in mutton samples were observed in the range of 85.9%–95.7%, with relative standard deviations <8.0% (n = 3). Application tests demonstrated this newly developed determination was practical, accurate, and convenient for detecting trace content β‐agonists in meat. [ABSTRACT FROM AUTHOR]